News
Public · Published
Nutex Health Initiated at Buy by Ladenburg Thalmann
Ladenburg Thalmann started coverage of Nutex Health with a Buy rating and set a price target of $336.00 per share, according to ratings actions reported by Benzinga.
Published:
Updated:
What happened
Ladenburg Thalmann started coverage of Nutex Health with a Buy rating and set a price target of $336.00 per share, according to ratings actions reported by Benzinga.
Confirmed
Global impact / market context
A Buy rating means the analyst expects the stock to rise, and the $336.00 target is the analyst's expected share price. New coverage can draw investor attention to Nutex Health and support demand for its shares.
Analyst inference
Nutex Health now has a published analyst rating and price target, which gives investors an outside view of its value. The article gives no financial results, so the rating rests on the analyst's own assessment rather than reported company numbers.
Analyst inference
What to watch
- Nutex Health was initiated at Buy by Ladenburg Thalmann with a $336.00 per share price target. Confirmed
- Watch whether other analysts begin covering Nutex Health, which would add more views on its value. Proposed
- Watch Nutex Health's next financial results, since actual revenue and profit could test whether the $336.00 target holds. Analyst inference
Evidence
- Original source link unavailable